C. Ballas, L. Lakkas, O. Kardakari, E. Papaioannou, Konstantinos C Siaravas, Katerina K. Naka, L. Michalis, C. Katsouras
{"title":"院内与院外肺栓塞:临床特征、生化标志物和超声心动图指标","authors":"C. Ballas, L. Lakkas, O. Kardakari, E. Papaioannou, Konstantinos C Siaravas, Katerina K. Naka, L. Michalis, C. Katsouras","doi":"10.3390/jcdd11040103","DOIUrl":null,"url":null,"abstract":"Background: A significant proportion of pulmonary embolisms (PEs) occurs in patients during hospitalisation for another reason. However, limited data regarding differences between out-of-hospital PE (OHPE) and in-hospital PE (IHPE) is available. We aimed to compare these groups regarding their clinical characteristics, biochemical markers, and echocardiographic indices. Methods: This was a prospective, single-arm, single-centre study. Adult consecutive patients with non-COVID-related PE from September 2019 to March 2022 were included and followed up for 12 months. Results: The study included 180 (84 women) patients, with 89 (49.4%) suffering from IHPE. IHPE patients were older, they more often had cancer, were diagnosed earlier after the onset of symptoms, they had less frequent pain and higher values of high sensitivity troponin I and brain natriuretic peptide levels compared to OHPE patients. Echocardiographic right ventricular (RV) dysfunction was detected in similar proportions in the 2 groups. IHPE had increased in-hospital mortality (14.6% vs. 3.3%, p = 0.008) and similar post-discharge to 12-month mortality with OHPE patients. Conclusions: In this prospective cohort study, IHPE differed from OHPE patients regarding age, comorbidities, symptoms, and levels of biomarkers associated with RV dysfunction. IHPE patients had higher in-hospital mortality compared to OHPE patients and a similar risk of death after discharge.","PeriodicalId":502527,"journal":{"name":"Journal of Cardiovascular Development and Disease","volume":"62 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices\",\"authors\":\"C. Ballas, L. Lakkas, O. Kardakari, E. Papaioannou, Konstantinos C Siaravas, Katerina K. Naka, L. Michalis, C. Katsouras\",\"doi\":\"10.3390/jcdd11040103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: A significant proportion of pulmonary embolisms (PEs) occurs in patients during hospitalisation for another reason. However, limited data regarding differences between out-of-hospital PE (OHPE) and in-hospital PE (IHPE) is available. We aimed to compare these groups regarding their clinical characteristics, biochemical markers, and echocardiographic indices. Methods: This was a prospective, single-arm, single-centre study. Adult consecutive patients with non-COVID-related PE from September 2019 to March 2022 were included and followed up for 12 months. Results: The study included 180 (84 women) patients, with 89 (49.4%) suffering from IHPE. IHPE patients were older, they more often had cancer, were diagnosed earlier after the onset of symptoms, they had less frequent pain and higher values of high sensitivity troponin I and brain natriuretic peptide levels compared to OHPE patients. Echocardiographic right ventricular (RV) dysfunction was detected in similar proportions in the 2 groups. IHPE had increased in-hospital mortality (14.6% vs. 3.3%, p = 0.008) and similar post-discharge to 12-month mortality with OHPE patients. Conclusions: In this prospective cohort study, IHPE differed from OHPE patients regarding age, comorbidities, symptoms, and levels of biomarkers associated with RV dysfunction. IHPE patients had higher in-hospital mortality compared to OHPE patients and a similar risk of death after discharge.\",\"PeriodicalId\":502527,\"journal\":{\"name\":\"Journal of Cardiovascular Development and Disease\",\"volume\":\"62 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Development and Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/jcdd11040103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Development and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/jcdd11040103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:相当一部分肺栓塞(PE)发生在因其他原因住院的患者身上。然而,有关院外肺栓塞(OHPE)和院内肺栓塞(IHPE)之间差异的数据非常有限。我们旨在比较这两组患者的临床特征、生化指标和超声心动图指标。方法:这是一项前瞻性、单臂、单中心研究。研究纳入了2019年9月至2022年3月期间连续就诊的非COVID相关PE成人患者,并随访12个月。研究结果研究共纳入 180 名(84 名女性)患者,其中 89 名(49.4%)为 IHPE 患者。与 OHPE 患者相比,IHPE 患者年龄更大,更常罹患癌症,在症状出现后更早确诊,疼痛次数更少,高敏肌钙蛋白 I 和脑钠肽水平值更高。超声心动图显示,两组患者的右心室(RV)功能障碍比例相似。IHPE患者的院内死亡率增加(14.6% vs. 3.3%,p = 0.008),出院后12个月的死亡率与OHPE患者相似。结论:在这项前瞻性队列研究中,IHPE与OHPE患者在年龄、合并症、症状以及与RV功能障碍相关的生物标志物水平方面存在差异。与 OHPE 患者相比,IHPE 患者的院内死亡率更高,出院后的死亡风险相似。
In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices
Background: A significant proportion of pulmonary embolisms (PEs) occurs in patients during hospitalisation for another reason. However, limited data regarding differences between out-of-hospital PE (OHPE) and in-hospital PE (IHPE) is available. We aimed to compare these groups regarding their clinical characteristics, biochemical markers, and echocardiographic indices. Methods: This was a prospective, single-arm, single-centre study. Adult consecutive patients with non-COVID-related PE from September 2019 to March 2022 were included and followed up for 12 months. Results: The study included 180 (84 women) patients, with 89 (49.4%) suffering from IHPE. IHPE patients were older, they more often had cancer, were diagnosed earlier after the onset of symptoms, they had less frequent pain and higher values of high sensitivity troponin I and brain natriuretic peptide levels compared to OHPE patients. Echocardiographic right ventricular (RV) dysfunction was detected in similar proportions in the 2 groups. IHPE had increased in-hospital mortality (14.6% vs. 3.3%, p = 0.008) and similar post-discharge to 12-month mortality with OHPE patients. Conclusions: In this prospective cohort study, IHPE differed from OHPE patients regarding age, comorbidities, symptoms, and levels of biomarkers associated with RV dysfunction. IHPE patients had higher in-hospital mortality compared to OHPE patients and a similar risk of death after discharge.